Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Capital Expenditures (2016 - 2025)

Iridex (IRIX) has 15 years of Capital Expenditures data on record, last reported at $13000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 1200.0% year-over-year to $13000.0; the TTM value through Sep 2025 reached $46000.0, up 264.29%, while the annual FY2024 figure was $13000.0, 88.07% down from the prior year.
  • Capital Expenditures reached $13000.0 in Q3 2025 per IRIX's latest filing, roughly flat from $13000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $126000.0 in Q1 2022 and bottomed at -$32000.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $40250.0, with a median of $21000.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: tumbled 138.55% in 2023, then soared 1200.0% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $73000.0 in 2021, then grew by 13.7% to $83000.0 in 2022, then crashed by 138.55% to -$32000.0 in 2023, then surged by 128.12% to $9000.0 in 2024, then soared by 44.44% to $13000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $13000.0 in Q3 2025, $13000.0 in Q2 2025, and $11000.0 in Q1 2025.